OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $0 | -100.0% | 10 | -99.9% | 0.00% | – |
Q4 2016 | $56,000 | -99.9% | 11,431 | -0.3% | 0.00% | – |
Q3 2016 | $56,847,000 | -2.4% | 11,461 | +0.1% | 0.00% | – |
Q2 2016 | $58,250,000 | -10.4% | 11,444 | +1.6% | 0.00% | – |
Q1 2016 | $65,000,000 | -44.4% | 11,269 | 0.0% | 0.00% | – |
Q4 2015 | $117,000,000 | +55880.9% | 11,269 | -0.2% | 0.00% | -100.0% |
Q3 2015 | $209,000 | -99.9% | 11,289 | +0.1% | 0.00% | 0.0% |
Q2 2015 | $219,431,000 | +3.8% | 11,276 | -6.2% | 0.00% | 0.0% |
Q1 2015 | $211,400,000 | +9.9% | 12,025 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $192,280,000 | +22.2% | 12,025 | -3.8% | 0.00% | 0.0% |
Q3 2014 | $157,337,000 | -19.5% | 12,497 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $195,344,000 | +32.0% | 12,506 | +10.9% | 0.00% | 0.0% |
Q1 2014 | $148,014,000 | -16.3% | 11,273 | +2.5% | 0.00% | 0.0% |
Q4 2013 | $176,912,000 | -14.4% | 11,002 | -11.5% | 0.00% | 0.0% |
Q3 2013 | $206,768,000 | +81.1% | 12,426 | +9.6% | 0.00% | 0.0% |
Q2 2013 | $114,154,000 | – | 11,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,240,709 | $23,259,000 | 3.12% |
PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $361,000 | 0.25% |
Freedom Investment Management, Inc. | 118,284 | $1,228,000 | 0.09% |
Spark Investment Management LLC | 62,800 | $651,000 | 0.08% |
GSA CAPITAL PARTNERS LLP | 98,901 | $1,027,000 | 0.05% |
Baker Brothers Advisors | 499,193 | $5,182,000 | 0.04% |
KILLEN GROUP INC | 31,000 | $322,000 | 0.03% |
GROUP ONE TRADING, L.P. | 127,263 | $1,321,000 | 0.02% |
A.R.T. Advisors, LLC | 27,049 | $280,000 | 0.01% |
QS Investors, LLC | 132,027 | $1,370,000 | 0.01% |